SWAYZE ERIC (SVP, Research) sold 12.0% of their position (53.00 shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $2.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/20/2026ACC: 0000874015-26-000266
Officer· SVP, Research
Since Jan 2020
-53.00
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
125.00 acquired · 178.00 disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+125.00
Price / share
—
Trade value
—
% of position
39.3%
10/15/2026
318.00→443.00
Common Stock
Indirect
Shares
−53.00
Price / share
$43.54
Trade value
$2.31K
% of position
12.0%
10/16/2026
443.00→390.00
Total
Net shares
+72.00
Net value
-$2.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/15/2026 | M · Option Exercise | +125.00 | — | — | 39.3% | 318.00 | 443.00 |
| Common Stock Indirect | 10/16/2026 | S · Sale | −53.00 | $43.54 | $2.31K | 12.0% | 443.00 | 390.00 |
| Total | +72.00 | -$2.31K | ||||||
Derivative Transactions1
Restricted Stock Unit
Indirect
Converts to
Common Stock
125.00 shares
Shares
−125.00
Strike price
0.0
Held after
486.00
Exercisable
—
10/15/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Indirect | Common Stock125.00 shares | 10/15/2026 | M · Option Exercise | −125.00 | 0.0 | — | 486.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned21.76K
Total
21.76K direct21.76K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 21.76K | Direct |
| Total | 21.76K | 21.76K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported